Skip to main content
Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.340
+0.037 (1.61%)
At close: Dec 5, 2025, 4:00 PM EST
2.320
-0.020 (-0.85%)
After-hours: Dec 5, 2025, 7:19 PM EST

Biomerica Revenue

Biomerica had revenue of $1.38M in the quarter ending August 31, 2025, a decrease of -23.63%. This brings the company's revenue in the last twelve months to $4.88M, down -11.35% year-over-year. In the fiscal year ending May 31, 2025, Biomerica had annual revenue of $5.31M, down -1.92%.

Revenue (ttm)
$4.88M
Revenue Growth
-11.35%
P/S Ratio
1.16
Revenue / Employee
$90,444
Employees
54
Market Cap
6.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 20255.31M-104.00K-1.92%
May 31, 20245.42M76.00K1.42%
May 31, 20235.34M-13.53M-71.71%
May 31, 202218.87M11.67M162.13%
May 31, 20217.20M506.32K7.57%
May 31, 2020 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

BMRA News

More News